HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ruth E Langley Selected Research
Ruth E Langley Research Topics
Disease
18
Prostatic Neoplasms (Prostate Cancer)
10/2022 - 04/2007
16
Neoplasms (Cancer)
01/2022 - 11/2005
11
Adenocarcinoma
01/2022 - 07/2006
4
Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2017
4
Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 05/2011
3
Neoplasm Metastasis (Metastasis)
01/2022 - 05/2007
3
Esophageal Neoplasms (Esophageal Cancer)
09/2021 - 10/2009
3
Carcinoma (Carcinomatosis)
01/2017 - 12/2015
2
Disease Progression
01/2022 - 04/2013
2
Microsatellite Instability
10/2021 - 12/2019
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 10/2016
2
Osteoporosis
01/2014 - 04/2013
2
Breast Neoplasms (Breast Cancer)
05/2007 - 11/2005
1
Hypertension (High Blood Pressure)
01/2022
1
Sudden Death
01/2022
1
Septic Shock (Toxic Shock Syndrome)
01/2022
1
Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2022
1
Cardiovascular Diseases (Cardiovascular Disease)
10/2021
1
Turcot syndrome
10/2021
1
Hemorrhage
10/2021
1
Peptic Ulcer (Peptic Ulcers)
10/2021
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2021
1
Ovarian Neoplasms (Ovarian Cancer)
01/2020
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020
1
Infections
01/2017
1
Neutropenia
01/2017
1
Anastomotic Leak
01/2017
1
Brain Neoplasms (Brain Tumor)
10/2016
1
Lung Neoplasms (Lung Cancer)
10/2016
1
Erythema Nodosum
12/2015
1
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
07/2014
1
Colonic Neoplasms (Colon Cancer)
05/2014
1
Erectile Dysfunction
01/2014
1
Muscle Weakness
01/2014
1
Hot Flashes
01/2014
1
Urethral Stricture
04/2007
Drug/Important Bio-Agent (IBA)
12
Androgens
IBA
10/2022 - 04/2007
8
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2013
7
Hormones (Hormone)
IBA
10/2022 - 04/2013
7
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
10/2021 - 01/2013
3
Prednisolone (Predate)
FDA Link
Generic
10/2022 - 01/2022
3
Abiraterone Acetate
IBA
10/2022 - 01/2022
3
Estradiol (Delestrogen)
FDA Link
Generic
01/2021 - 01/2016
3
Testosterone (Sustanon)
FDA Link
01/2021 - 01/2014
3
Pharmaceutical Preparations
IBA
01/2021 - 01/2013
3
Cisplatin (Platino)
FDA Link
Generic
01/2017 - 07/2006
3
Epirubicin (Ellence)
FDA Link
Generic
01/2017 - 11/2005
3
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
12/2015 - 08/2008
3
Estrogens (Estrogen)
FDA Link
12/2015 - 02/2013
2
antiarrhythmic peptide (AAP)
IBA
10/2022 - 01/2022
2
abiraterone
IBA
10/2022 - 01/2022
2
DNA (Deoxyribonucleic Acid)
IBA
11/2020 - 12/2019
2
Capecitabine (Xeloda)
FDA Link
01/2017 - 01/2017
2
Bevacizumab (Avastin)
FDA Link
01/2017 - 01/2017
2
Fluorouracil (Carac)
FDA Link
Generic
01/2017 - 07/2006
1
Prednisone (Sone)
FDA Link
Generic
10/2022
1
Docetaxel (Taxotere)
FDA Link
10/2022
1
Acetates (Acetic Acid Esters)
FDA Link
01/2022
1
enzalutamide
IBA
01/2022
1
Mucins
IBA
01/2022
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2022
1
Alanine (L-Alanine)
FDA Link
01/2022
1
Eosine Yellowish-(YS) (Eosin)
IBA
10/2021
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2021
1
Paraffin
IBA
11/2020
1
Formaldehyde (Formol)
FDA Link
11/2020
1
Lapatinib (GW572016)
FDA Link
08/2019
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2017
1
Monoclonal Antibodies
IBA
01/2017
1
Dexamethasone (Maxidex)
FDA Link
Generic
10/2016
1
Elements
IBA
10/2016
1
Quartz
IBA
10/2016
1
Histocompatibility Antigens Class I
IBA
05/2014
1
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
05/2014
1
Antigens
IBA
05/2014
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
05/2014
1
Therapeutic Uses
IBA
01/2013
1
Toremifene (Fareston)
FDA Link
06/2011
1
Diphosphonates (Bisphosphonates)
IBA
05/2007
1
Clodronic Acid (Clodronate)
IBA
05/2007
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2005
1
Paclitaxel (Taxol)
FDA Link
Generic
11/2005
Therapy/Procedure
18
Therapeutics
10/2022 - 08/2008
11
Drug Therapy (Chemotherapy)
01/2020 - 11/2005
6
Radiotherapy
01/2022 - 04/2007
6
Neoadjuvant Therapy
01/2022 - 11/2016
1
Immunotherapy
10/2021
1
Chemoprevention
01/2021
1
Combined Modality Therapy
08/2020
1
Adjuvant Chemotherapy
12/2019
1
Aftercare (After-Treatment)
10/2016
1
Conformal Radiotherapy
04/2007